Question 1

What are the potential risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) clinical trial (NCT00966030). Contact the study team or your healthcare provider for specific answers.

Question 2

How does the tablet version of MK0974 compare to other migraine treatments I may be considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) clinical trial (NCT00966030). Contact the study team or your healthcare provider for specific answers.

Question 3

What kind of monitoring will I receive during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) clinical trial (NCT00966030). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any side effects I should be aware of from either the tablet or the capsule?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) clinical trial (NCT00966030). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be assessed before and during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) clinical trial (NCT00966030). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects during the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Bioequivalence of the Tablet and Liquid-Filled Capsule Forms of MK0974 (0974-042) clinical trial (NCT00966030). Contact the study team or your healthcare provider for specific answers.

What this study is about